Santos LL - Search Results

1

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids.

Loureiro LR, Sousa DP, Ferreira D, Chai W, Lima L, Pereira C, Lopes CB, Correia VG, Silva LM, Li C, Santos LL, Ferreira JA, Barbas A, Palma AS, Novo C, Videira PA. Loureiro LR, et al. Among authors: santos ll. Sci Rep. 2018 Aug 15;8(1):12196. doi: 10.1038/s41598-018-30421-w. Sci Rep. 2018. PMID: 30111774 Free PMC article.

2

Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours.

Santos L, Costa C, Pereira S, Koch M, Amaro T, Cardoso F, Guimarães T, Bento MJ, Lobo F, Pinto S, Lopes C. Santos L, et al. Ann Oncol. 2003 Sep;14(9):1419-24. doi: 10.1093/annonc/mdg377. Ann Oncol. 2003. PMID: 12954582 Free article.

3

MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease.

Pinto C, Veiga I, Pinheiro M, Mesquita B, Jeronimo C, Sousa O, Fragoso M, Santos L, Moreira-Dias L, Baptista M, Lopes C, Castedo S, Teixeira MR. Pinto C, et al. Br J Cancer. 2006 Sep 18;95(6):752-6. doi: 10.1038/sj.bjc.6603318. Epub 2006 Aug 29. Br J Cancer. 2006. PMID: 16940983 Free PMC article.

4

DNA cytometry and kinetics of rat urothelial lesions during chemical carcinogenesis.

Palmeira C, Oliveira PA, Arantes-Rodrigues R, Colaço A, De la Cruz PL, Lopes C, Santos L. Palmeira C, et al. Oncol Rep. 2009 Jan;21(1):247-52. Oncol Rep. 2009. PMID: 19082469

5

CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.

Palmeira C, Lameiras C, Amaro T, Lima L, Koch A, Lopes C, Oliveira PA, Santos L. Palmeira C, et al. Urol Oncol. 2011 Mar-Apr;29(2):205-11. doi: 10.1016/j.urolonc.2009.07.022. Epub 2009 Oct 24. Urol Oncol. 2011. PMID: 19854077

6

Effects of bevacizumab on autocrine VEGF stimulation in bladder cancer cell lines.

Videira PA, Piteira AR, Cabral MG, Martins C, Correia M, Severino P, Gouveia H, Carrascal M, Almeida JF, Trindade H, Santos LL. Videira PA, et al. Among authors: santos ll. Urol Int. 2011;86(1):95-101. doi: 10.1159/000321905. Epub 2011 Jan 8. Urol Int. 2011. PMID: 21212629

7

Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions.

Vasconcelos-Nóbrega C, Colaço A, Santos L, Vala H, Palomino LF, Lopes C, Oliveira PA. Vasconcelos-Nóbrega C, et al. Anticancer Res. 2011 May;31(5):1637-42. Anticancer Res. 2011. PMID: 21617220

8

CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis.

Afonso J, Longatto-Filho A, Baltazar F, Sousa N, Costa FE, Morais A, Amaro T, Lopes C, Santos LL. Afonso J, et al. Among authors: santos ll. Eur J Surg Oncol. 2011 Sep;37(9):811-7. doi: 10.1016/j.ejso.2011.06.006. Epub 2011 Jul 5. Eur J Surg Oncol. 2011. PMID: 21733655 Free article.

9

IL-4 and TNF-α polymorphisms are associated with risk of multiple superficial tumors or carcinoma in situ development.

Lima L, Silva J, Amaro T, Morais A, Lopes C, Medeiros R, Videira PA, Santos L. Lima L, et al. Urol Int. 2011;87(4):457-63. doi: 10.1159/000331882. Epub 2011 Nov 18. Urol Int. 2011. PMID: 22104567

10

Predictive biomarkers of bacillus calmette-guérin immunotherapy response in bladder cancer: where are we now?

Lima L, Dinis-Ribeiro M, Longatto-Filho A, Santos L. Lima L, et al. Adv Urol. 2012;2012:232609. doi: 10.1155/2012/232609. Epub 2012 Aug 7. Adv Urol. 2012. PMID: 22919375 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters